Photo from wikipedia
To evaluate linagliptin prescribing in type 2 diabetes mellitus patients with different comorbidities, an expanded Japanese post‐marketing surveillance also collected baseline data for patients initiating other glucose‐lowering drugs. Click to show full abstract
To evaluate linagliptin prescribing in type 2 diabetes mellitus patients with different comorbidities, an expanded Japanese post‐marketing surveillance also collected baseline data for patients initiating other glucose‐lowering drugs.
Keywords:
type diabetes;
linagliptin;
post marketing;
marketing surveillance
Journal Title: Journal of Diabetes Investigation
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Diabetes Investigation
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!